NanoViricides
NNVC
#10125
Rank
A$33.35 M
Marketcap
A$1.85
Share price
-1.60%
Change (1 day)
-20.28%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of September 2025 : A$10.8 Million

According to NanoViricides's latest financial reports the company has A$10.8 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$A$17.17 M-23%
2023-06-30$A$22.3 M-33.34%
2022-06-30$A$33.46 M-16.12%
2021-06-30$A$39.89 M26.55%
2020-06-30$A$31.52 M108.86%
2019-06-30$A$15.09 M-36.75%
2018-06-30$A$23.86 M-9.85%
2017-06-30$A$26.46 M-14.46%
2016-06-30$A$30.94 M-25.1%
2015-06-30$A$41.31 M66.69%
2014-06-30$A$24.78 M182.47%
2013-06-30$A$8.77 M-35.12%
2012-06-30$A$13.52 M42.5%
2011-06-30$A$9.48 M23.31%
2010-06-30$A$7.69 M150.49%
2009-06-30$A$3.07 M562.19%
2008-06-30$A$0.46 M-21.48%
2007-06-30$A$0.59 M-64.71%
2006-06-30$A$1.67 M-2035.6%
2005-06-30$-A$0.09 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
-A$0.59 Billion-5,506.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$0.24 Billion-2,283.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$32.32 B 298,951.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.02 B 259,144.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$78.20 B 723,373.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$31.90 B 295,048.64%๐Ÿ‡ฌ๐Ÿ‡ง UK